SE HABLA ESPAÑOL | MAP
312-739-4200
Contact Us

Contact Us

Archives

  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013

  • Areas & Topics

    Frquently Asked Questions

    Our Office Location

    Edelman, Combs, Latturner, & Goodwin, LLC

    20 South Clark Street
    Suite 1500
    Chicago, IL 60603

    info@edcombs.com
    Phone: 312-739-4200
    Fax: 312-419-0379


    E-mail Us  |  Chicago Law Office

    Edelman Combs Latturner Goodwin's facebook page   Edelman Combs Latturner Goodwin's Twitter Page   Edelman Combs Latturner Goodwin's Google Plus Page

    FTC Action Stops Unsupported Claims for Opiate Withdrawal Treatments

    FTC Action Stops Unsupported Claims for Opiate Withdrawal Treatments

    Defendants claimed herbal products alleviated symptoms of opiate withdrawal and helped users overcome opiate dependency

    FOR RELEASE

    A company that marketed itself as “the leader in home opiate detox since 2009” and its CEO have settled Federal Trade Commission charges that the withdrawal treatment claims for their “Withdrawal Ease” and “Recovery Ease” products were false or unsupported by scientific evidence.

    The court order settling the FTC’s charges bars Catlin Enterprises, Inc. and George Catlin, based in Austin, Texas, from making claims about opiate withdrawal, opiate dependency, or other health conditions, including through their product names, unless they possess competent and reliable science to back up those claims.

    “Opioid addiction is a scourge that has affected millions of Americans,” said Acting FTC Chairman Maureen K. Ohlhausen. “People who struggle with this problem need real help, not phony claims and false promises like the ones peddled by these defendants.”

    According to the FTC’s complaint, the defendants violated the FTC Act by making unsubstantiated claims that Withdrawal Ease: 1) significantly alleviated the symptoms of opiate withdrawal; and 2) significantly increased the likelihood of a person overcoming opiate dependency. The defendants also allegedly misrepresented that clinical studies proved Withdrawal Ease’s effectiveness. The complaint charges the defendants with deceptively representing that Recovery Ease significantly alleviated long-term opiate withdrawal symptoms.

    The proposed order settling the FTC’s complaint prohibits the defendants from making health claims, including claims that their products can alleviate withdrawal symptoms or help with drug dependency, unless the claims are non-misleading and are substantiated by scientific evidence. The terms of the order are very similar to those in the FTC’s recent case against Sunrise Nutraceuticals, another company that the FTC alleged lacked the necessary scientific evidence to prove its herbal product helped with opiate withdrawal.

    Finally, the proposed order imposes a $6.6 million judgment against the defendants, which will be suspended based on their inability to pay.

    The Commission vote authorizing the staff to file the complaint and to approve the stipulated proposed order was 2-0. The FTC filed the complaint and proposed order in the U.S. District Court for the Western District of Texas.

    NOTE: The Commission files a complaint when it has “reason to believe” that the law has been or is being violated and it appears to the Commission that a proceeding is in the public interest. Stipulated court orders have the force of law when approved and signed by the District Court judge.